Dr Browne's hand sanitiser, one of the strongest on the market, killing 99.9999% of viruses with an 80% alcohol concentration.
Unlike most hand sanitisers Dr Browne's has been tested against viruses and used widely by the NHS to provide premium protection. Available in Lemongrass or lavender essence, leaving a luscious smell, while fighting to keep you safe. The 50ml bottle size is the perfect size to keep you protected at all times. It can also be taken on flights in your hand luggage. Dr Browne's is perfect to protect you, your family, friends and colleagues.
Also available on Amazon for single unit purchase
Key Features:
- 80% alcohol concentration
- Kills 99.9999% of virus
- Proudly made in Britain
- Scented
- As used by the NHS
- Eco-Friendly
- Quick Drying
- Can be used as a surface cleaner
Dr Browne's is approved to:
EN 1276:2019
EN 1500:2013
EN 13624:2013
EN 13727:2012 + A2:2015
EN 14476:2013 + A2:2019
Also available in 220ml, 475ml & 5L
center>
Also available on
For trade orders, please place your order here with your login to the trade shop (contact us for a login if you do not already have one).
BCB Saving Lives.
About Dr. Browne
In 1854, a Dr Browne came up with a cough medicine and shipped some off to British troops suffering in the trenches in the Crimean war. 60 years later, Dr Browne's Cough Bottle gave the initials for a registered company, BCB.
“Dr. Browne” has now been called back to do his duty for the community/country.
BCB International has put its experts to the task and created a number of new products to help combat current events including three specialist survival packs designed to help all of our lives, see our related products or visit the Personal Protection Equipment section on our website to find out more.
Soap versus sanitiser for preventing the transmission of acute respiratory infections in the community: a systematic review with meta-analysis and dose-response analysis.
Link: Tammy Hoffmann 1, et al.
Summary of abstract
Objective: To compare the effectiveness of hand hygiene using alcohol-based hand sanitiser to soap and water for preventing the transmission of acute respiratory infections (ARIs) and to assess the relationship between the dose of hand hygiene and the number of ARI, influenza-like illness (ILI) or influenza events.
Results: Eighteen trials were included. When meta-analysed, three trials of soap and water versus control found a non-significant increase in ARI events (risk ratio (RR) 1.23, 95% CI 0.78 to 1.93); six trials of sanitiser versus control found a significant reduction in ARI events (RR 0.80, 95% CI 0.71 to 0.89).
Conclusions: Adequately performed hand hygiene, with either soap or sanitiser, reduces the risk of ARI virus transmission; however, direct and indirect evidence suggest sanitiser might be more effective in practice.